Cytokinetics

We are incredibly proud to announce the release of Resilience in the Fight Against ALS, the story of our decade-long journey to discover and develop a potential medicine for ALS. We endured both challenges and triumphs in our journey in #ALS, and our goal to bring forward a new medicine for people living with ALS was not realized. However, while some may deem that a defeat, we see it as anything but that. In fact, we are grateful for the opportunities our dedication to the fight against ALS has afforded us. The book recounts our company’s lessons and learnings and serves to pass the baton to those developing potential new medicines for ALS to help light the path to future success. It also highlights many key individuals, including people living with ALS, caregivers, advocates and clinicians who inspired us along the way. Resilience in the Fight Against ALS is now available as a free eBook and downloadable PDF. Learn more here. https://bit.ly/4bVKy04

August is Transgender History Month! Join us in lifting up the voices of transgender people and honoring the legacy of those who have paved the way for a more inclusive world. Learn more: https://bit.ly/3SiK90A

We are pleased to announce the launch of our Corporate Giving Program, which will provide charitable donations to eligible non-profit organizations in the United States to support diversity in science education, equitable healthcare initiatives for cardiovascular disease and certain essential services for local and at-risk communities. To learn more about the program, visit: https://bit.ly/3yakctk #philanthropy #DiversityandInclusion #STEMeducation #HealthEquity

Cytokinetics is dedicated to reducing our waste. Did you know that it’s Plastic-Free July? This global movement from the Plastic Free July Foundation challenges us to refuse single-use plastics. Let’s create a more #sustainable world through our actions big and small. Find tips here: https://bit.ly/3yfli6X #plasticfreejuly

The ALS Therapy Development Institute (ALS TDI) is a recipient of our 2024 Communications Grant program. With the grant, they will launch the ALS Trial Navigator. This unique online #platform will guide #patients as they learn more about finding and participating in clinical trials for experimental #ALS #treatments. https://bit.ly/4cK9oBd

We are happy to share that Cytokinetics is one of Great Place To Work US & Fortune's top 100 #BestWorkplaces for #Millennials! A huge thank you to everyone who makes Cytokinetics an exceptional place to work. https://bit.ly/3Lxc8G1

We are pleased to announce seven upcoming presentations, including four late-breaking clinical trial presentations related to our investigational cardiac myosin inhibitor at the European Society of Cardiology Congress 2024 in #London Aug. 30 – Sept. 2, 2024. #ESCCongress #HCM https://bit.ly/4cLL1my

There’s never been a better time to join our team if you are looking for a career to empower yourself, empower your community and empower patients.     At Cytokinetics, you’ll work on a team of talented individuals who share a common goal of developing potential medicines for people with diseases of impaired muscle function.     If you are interested in a career at a biopharmaceutical company where you will feel empowered in the work you do, check out our open positions. https://bit.ly/4bKRM6I #EmpoweredAtCytokinetics #hiring

Happy 4th of July! We hope you have a great holiday.

July is Disability Pride Month! Let's elevate the contributions and experiences of people with disabilities, fight stigma, and advocate for a more inclusive world. #DisabilityPride